RXO (NYSE:RXO) Hits New 52-Week High – Should You Buy?

Rxo Inc (NYSE:RXOGet Free Report)’s stock price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $23.69 and last traded at $23.5460, with a volume of 1257942 shares trading hands. The stock had previously closed at $21.13.

Analyst Ratings Changes

A number of research analysts recently issued reports on RXO shares. Wall Street Zen upgraded RXO from a “sell” rating to a “hold” rating in a report on Saturday, May 9th. Bank of America decreased their price target on RXO from $17.00 to $15.00 and set a “neutral” rating for the company in a report on Wednesday, March 25th. Susquehanna lifted their price target on RXO from $14.00 to $18.00 and gave the stock a “negative” rating in a report on Friday, May 8th. UBS Group lifted their price target on RXO from $17.00 to $22.00 and gave the stock a “neutral” rating in a report on Friday, May 8th. Finally, Citigroup lifted their price target on RXO from $17.00 to $24.00 and gave the stock a “neutral” rating in a report on Friday, May 8th. Three research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, RXO presently has an average rating of “Hold” and a consensus price target of $20.08.

Read Our Latest Report on RXO

RXO Price Performance

The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.28. The firm has a market capitalization of $3.85 billion, a PE ratio of -38.42, a P/E/G ratio of 21.24 and a beta of 1.96. The company has a fifty day moving average price of $16.64 and a two-hundred day moving average price of $15.13.

RXO (NYSE:RXOGet Free Report) last posted its earnings results on Thursday, May 7th. The company reported ($0.09) earnings per share for the quarter, meeting the consensus estimate of ($0.09). RXO had a negative return on equity of 1.16% and a negative net margin of 1.83%.The business had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.34 billion. During the same period in the previous year, the business earned ($0.03) EPS. The business’s quarterly revenue was down .6% on a year-over-year basis. Sell-side analysts forecast that Rxo Inc will post 0.06 earnings per share for the current year.

Institutional Trading of RXO

Institutional investors and hedge funds have recently made changes to their positions in the company. Geneos Wealth Management Inc. purchased a new stake in shares of RXO in the 1st quarter valued at about $30,000. Cassaday & Co Wealth Management LLC acquired a new position in RXO in the 1st quarter valued at about $29,000. Flagship Harbor Advisors LLC acquired a new position in RXO in the 4th quarter valued at about $25,000. Quarry LP acquired a new position in RXO in the 3rd quarter valued at about $33,000. Finally, Larson Financial Group LLC increased its position in RXO by 146.5% in the 3rd quarter. Larson Financial Group LLC now owns 2,766 shares of the company’s stock valued at $43,000 after acquiring an additional 1,644 shares during the period. 92.73% of the stock is owned by hedge funds and other institutional investors.

About RXO

(Get Free Report)

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.

Recommended Stories

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.